Clinical Trial Update: SINEFIX-2022 Pilot Phase [NA]

View source ↗

Summary

Status update: the SINEFIX-2022 Pilot Phase trial is currently active but not recruiting for Rotator cuff tear treatment. Sponsor: BAAT Medical Products B.V.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Tear

Drugs mentioned

• SINEFIX-2022

Snippet

Sponsor: BAAT Medical Products B.V. | Conditions: Rotator Cuff Tears (RCTs) | NA | Status: ACTIVE_NOT_RECRUITING